# OnCo record morphosys (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/morphosys/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "morphosys" ;
  schema:name "MorphoSys (Novartis)"@en ;
  schema:description "German antibody company that acquired Constellation's BET inhibitor pelabresib and was itself bought by Novartis in 2024."@en ;
  schema:url <https://onco.cc/companies/morphosys/>, <https://www.morphosys.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.morphosys.com> ;
  onco:status "historic" ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/epigenetics/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:companies <https://onco.cc/companies/novartis/> .